US Patent Issued to Deciphera Pharmaceuticals on July 28 for "Methods for treating vascular malformations" (Belgian, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,108, issued on July 28, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Methods for treating vascular malformations" was invented by Daniel L. Flynn (Waltham, Mass.), Bryan D. Smith (Waltham, Mass.) and Miikka Vikkula (Kraainem, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for inhibiting TIE2 kinase useful in the treatment of growth of venous malformations. Specifically, the disclosure relates to methods of using a compound of Formula I and salts thereof"

The patent was filed on Aug. 12, 2020, under Application No. 16/991,644.

*For further information, including images, charts an...